This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Joan M. Fletcher: Innovator in HIF Prolyl Hydroxylase Inhibitors
Introduction
Joan M. Fletcher is a notable inventor based in Edison, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can treat anemia and related conditions.
Latest Patents
Joan holds a patent for spiroindalone compounds, which are recognized for their utility as HIF prolyl hydroxylase inhibitors. This invention is crucial in addressing anemia and similar health issues. She has 1 patent to her name, showcasing her innovative approach to solving medical challenges.
Career Highlights
Joan is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. Her work at Merck has allowed her to focus on research and development in the pharmaceutical sector, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Joan has collaborated with esteemed colleagues, including Jeffrey John Hale and Shouwu Miao. These partnerships have enhanced her research efforts and have been instrumental in the development of her patented inventions.
Conclusion
Joan M. Fletcher exemplifies the spirit of innovation in the pharmaceutical industry. Her work on spiroindalone compounds highlights her commitment to improving health outcomes for patients suffering from anemia and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile